Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Liver Neoplasms | 13 | 2024 | 4253 | 0.690 |
Why?
|
Carcinoma, Hepatocellular | 9 | 2024 | 2214 | 0.650 |
Why?
|
Liver Cirrhosis | 15 | 2021 | 1862 | 0.540 |
Why?
|
Elasticity Imaging Techniques | 6 | 2021 | 388 | 0.540 |
Why?
|
Liver | 20 | 2021 | 7475 | 0.500 |
Why?
|
Esophageal Diseases | 2 | 2004 | 167 | 0.430 |
Why?
|
Hepatitis C, Chronic | 7 | 2014 | 1031 | 0.430 |
Why?
|
Hepatitis B virus | 2 | 2016 | 513 | 0.430 |
Why?
|
Choline Deficiency | 2 | 2019 | 28 | 0.300 |
Why?
|
Cholangiocarcinoma | 2 | 2021 | 516 | 0.300 |
Why?
|
Fibroblast Growth Factors | 3 | 2018 | 878 | 0.280 |
Why?
|
Hepatitis B | 1 | 2012 | 695 | 0.280 |
Why?
|
Hepacivirus | 2 | 2012 | 1379 | 0.250 |
Why?
|
Methionine | 2 | 2019 | 590 | 0.250 |
Why?
|
Hepatitis B, Chronic | 3 | 2016 | 393 | 0.250 |
Why?
|
Common Bile Duct Diseases | 1 | 2004 | 37 | 0.240 |
Why?
|
Carcinoma, Verrucous | 1 | 2003 | 23 | 0.230 |
Why?
|
Alanine Transaminase | 3 | 2012 | 592 | 0.220 |
Why?
|
Keratin-18 | 2 | 2015 | 39 | 0.220 |
Why?
|
Granuloma | 1 | 2004 | 319 | 0.200 |
Why?
|
Endoscopy, Gastrointestinal | 3 | 2018 | 868 | 0.190 |
Why?
|
Fatty Liver | 3 | 2014 | 727 | 0.190 |
Why?
|
Kupffer Cells | 2 | 2000 | 142 | 0.180 |
Why?
|
Liver Cirrhosis, Experimental | 1 | 2019 | 32 | 0.170 |
Why?
|
Hepatitis, Autoimmune | 1 | 2020 | 141 | 0.160 |
Why?
|
Receptors, Aryl Hydrocarbon | 1 | 2020 | 209 | 0.160 |
Why?
|
Ampulla of Vater | 1 | 2018 | 141 | 0.160 |
Why?
|
Apyrase | 1 | 2020 | 364 | 0.150 |
Why?
|
Esophagus | 1 | 2003 | 1019 | 0.150 |
Why?
|
Ventriculoperitoneal Shunt | 1 | 1998 | 194 | 0.150 |
Why?
|
Hepatic Stellate Cells | 2 | 2019 | 109 | 0.140 |
Why?
|
Biopsy | 10 | 2021 | 6755 | 0.140 |
Why?
|
Cyclic AMP-Dependent Protein Kinase Catalytic Subunits | 1 | 2016 | 11 | 0.140 |
Why?
|
Hepatitis B Core Antigens | 1 | 2016 | 92 | 0.140 |
Why?
|
Bile Duct Neoplasms | 1 | 2021 | 567 | 0.140 |
Why?
|
HSP40 Heat-Shock Proteins | 1 | 2016 | 80 | 0.140 |
Why?
|
Liver Transplantation | 3 | 2016 | 2119 | 0.130 |
Why?
|
Catheterization, Central Venous | 1 | 2000 | 514 | 0.130 |
Why?
|
Hypertension, Portal | 2 | 2014 | 220 | 0.130 |
Why?
|
Hepatitis B Surface Antigens | 1 | 2016 | 305 | 0.130 |
Why?
|
Salivary Glands, Minor | 1 | 1994 | 27 | 0.120 |
Why?
|
Forefoot, Human | 1 | 1994 | 32 | 0.120 |
Why?
|
Adenocarcinoma | 4 | 2012 | 6364 | 0.120 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2020 | 1115 | 0.120 |
Why?
|
Carcinoma | 2 | 1998 | 2375 | 0.120 |
Why?
|
Ischemia | 1 | 2003 | 1907 | 0.120 |
Why?
|
Ethiodized Oil | 1 | 1993 | 33 | 0.120 |
Why?
|
Gelatin Sponge, Absorbable | 1 | 1993 | 60 | 0.120 |
Why?
|
Th17 Cells | 1 | 2020 | 766 | 0.120 |
Why?
|
Histocytochemistry | 1 | 2014 | 719 | 0.120 |
Why?
|
Fats | 1 | 2014 | 102 | 0.110 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2020 | 2988 | 0.110 |
Why?
|
Foot Diseases | 1 | 1994 | 143 | 0.110 |
Why?
|
Cholangitis, Sclerosing | 1 | 2014 | 160 | 0.110 |
Why?
|
Chemoembolization, Therapeutic | 1 | 1993 | 129 | 0.110 |
Why?
|
Hyaluronic Acid | 3 | 2010 | 491 | 0.110 |
Why?
|
Isoantibodies | 1 | 2016 | 679 | 0.110 |
Why?
|
Hydrocephalus | 1 | 1998 | 748 | 0.100 |
Why?
|
Phosphatidate Phosphatase | 1 | 2011 | 21 | 0.100 |
Why?
|
Hepatitis, Chronic | 1 | 2011 | 52 | 0.100 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2003 | 2020 | 0.100 |
Why?
|
Crohn Disease | 1 | 2004 | 2304 | 0.100 |
Why?
|
Doxorubicin | 2 | 1997 | 2234 | 0.100 |
Why?
|
Axilla | 1 | 1993 | 597 | 0.100 |
Why?
|
Ethanol | 1 | 2017 | 1342 | 0.090 |
Why?
|
Salivary Gland Neoplasms | 1 | 1994 | 298 | 0.090 |
Why?
|
Clinical Enzyme Tests | 1 | 2010 | 115 | 0.090 |
Why?
|
Esophagogastric Junction | 1 | 2012 | 313 | 0.090 |
Why?
|
Epinephrine | 1 | 1993 | 792 | 0.090 |
Why?
|
Cell Proliferation | 3 | 2022 | 10483 | 0.090 |
Why?
|
Lipogenesis | 1 | 2011 | 212 | 0.090 |
Why?
|
Meningeal Neoplasms | 1 | 1998 | 1241 | 0.080 |
Why?
|
Aspartate Aminotransferases | 1 | 2010 | 418 | 0.080 |
Why?
|
Graft Rejection | 2 | 2016 | 4397 | 0.080 |
Why?
|
ROC Curve | 5 | 2016 | 3528 | 0.080 |
Why?
|
Leiomyoma | 1 | 1994 | 730 | 0.080 |
Why?
|
Endothelium, Vascular | 2 | 2004 | 4459 | 0.080 |
Why?
|
Endosonography | 1 | 2012 | 610 | 0.080 |
Why?
|
Predictive Value of Tests | 7 | 2018 | 15078 | 0.080 |
Why?
|
Triiodothyronine | 1 | 2009 | 494 | 0.080 |
Why?
|
Intestinal Mucosa | 1 | 2018 | 3037 | 0.070 |
Why?
|
Biopsy, Needle | 3 | 2006 | 1641 | 0.070 |
Why?
|
Diagnosis, Differential | 6 | 2006 | 12961 | 0.070 |
Why?
|
Bile Ducts | 2 | 2006 | 284 | 0.070 |
Why?
|
Fatty Acids | 1 | 2014 | 1809 | 0.070 |
Why?
|
Middle Aged | 25 | 2021 | 213390 | 0.070 |
Why?
|
Thrombosis | 1 | 2000 | 2968 | 0.070 |
Why?
|
Humans | 43 | 2021 | 744366 | 0.070 |
Why?
|
Palliative Care | 2 | 1998 | 3493 | 0.070 |
Why?
|
Lymphatic Metastasis | 1 | 1993 | 2924 | 0.070 |
Why?
|
Obesity | 4 | 2021 | 12746 | 0.060 |
Why?
|
Inflammation | 2 | 2007 | 10637 | 0.060 |
Why?
|
Disease Progression | 5 | 2019 | 13286 | 0.060 |
Why?
|
Transforming Growth Factor beta | 1 | 2012 | 2007 | 0.060 |
Why?
|
Male | 31 | 2021 | 350115 | 0.060 |
Why?
|
Soft Tissue Neoplasms | 1 | 1994 | 1363 | 0.060 |
Why?
|
Female | 27 | 2024 | 380193 | 0.060 |
Why?
|
Immunohistochemistry | 4 | 2016 | 11366 | 0.060 |
Why?
|
Collagen Type I | 2 | 2019 | 592 | 0.060 |
Why?
|
Adult | 22 | 2017 | 214052 | 0.060 |
Why?
|
Lactates | 1 | 2024 | 432 | 0.060 |
Why?
|
Pyruvic Acid | 1 | 2024 | 200 | 0.060 |
Why?
|
Vacuoles | 1 | 2003 | 229 | 0.060 |
Why?
|
Phosphofructokinase-2 | 1 | 2022 | 32 | 0.050 |
Why?
|
Rats, Inbred F344 | 1 | 2024 | 862 | 0.050 |
Why?
|
Docosahexaenoic Acids | 2 | 2006 | 875 | 0.050 |
Why?
|
Mice, Inbred C57BL | 6 | 2019 | 21833 | 0.050 |
Why?
|
Mice, Knockout | 5 | 2018 | 14561 | 0.050 |
Why?
|
Esophageal Neoplasms | 1 | 2012 | 1585 | 0.050 |
Why?
|
RNA-Binding Proteins | 1 | 2011 | 1903 | 0.050 |
Why?
|
Pilonidal Sinus | 1 | 2001 | 16 | 0.050 |
Why?
|
Keratins | 1 | 2003 | 515 | 0.050 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 2 | 2014 | 149 | 0.050 |
Why?
|
Lymph Nodes | 1 | 1993 | 3476 | 0.050 |
Why?
|
Antigens, CD1 | 1 | 2004 | 437 | 0.050 |
Why?
|
Colonography, Computed Tomographic | 1 | 2003 | 169 | 0.050 |
Why?
|
Condylomata Acuminata | 1 | 2001 | 82 | 0.050 |
Why?
|
Cell Size | 1 | 2003 | 643 | 0.050 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2004 | 451 | 0.050 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2004 | 437 | 0.050 |
Why?
|
Yttrium Radioisotopes | 1 | 2021 | 93 | 0.050 |
Why?
|
Vaginal Smears | 1 | 2003 | 511 | 0.050 |
Why?
|
Severity of Illness Index | 4 | 2014 | 15535 | 0.050 |
Why?
|
Anus Neoplasms | 1 | 2004 | 332 | 0.050 |
Why?
|
Biphenyl Compounds | 1 | 2004 | 913 | 0.050 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2021 | 295 | 0.040 |
Why?
|
Lipids | 1 | 2011 | 3307 | 0.040 |
Why?
|
Arteriosclerosis | 1 | 2004 | 1092 | 0.040 |
Why?
|
Sterol Regulatory Element Binding Protein 2 | 1 | 2019 | 52 | 0.040 |
Why?
|
Animals | 14 | 2024 | 168768 | 0.040 |
Why?
|
Animal Feed | 1 | 2019 | 110 | 0.040 |
Why?
|
Stearoyl-CoA Desaturase | 1 | 2019 | 86 | 0.040 |
Why?
|
Liver Neoplasms, Experimental | 1 | 2000 | 191 | 0.040 |
Why?
|
Benzimidazoles | 1 | 2004 | 850 | 0.040 |
Why?
|
Vimentin | 1 | 2000 | 262 | 0.040 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2012 | 4479 | 0.040 |
Why?
|
Catheterization | 1 | 2004 | 1470 | 0.040 |
Why?
|
Phlebography | 1 | 2000 | 333 | 0.040 |
Why?
|
Lymphocytosis | 1 | 1999 | 119 | 0.040 |
Why?
|
Tetrazoles | 1 | 2004 | 835 | 0.040 |
Why?
|
Necrosis | 1 | 2003 | 1643 | 0.040 |
Why?
|
Cytoplasm | 1 | 2003 | 1536 | 0.040 |
Why?
|
Microspheres | 1 | 2021 | 777 | 0.040 |
Why?
|
Glycolysis | 1 | 2022 | 829 | 0.040 |
Why?
|
Aortic Diseases | 1 | 2004 | 743 | 0.040 |
Why?
|
Random Allocation | 2 | 2017 | 2428 | 0.040 |
Why?
|
Nerve Tissue Proteins | 1 | 2011 | 4463 | 0.040 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2006 | 1131 | 0.040 |
Why?
|
HIV Seropositivity | 1 | 2004 | 971 | 0.040 |
Why?
|
Mice, Inbred BALB C | 2 | 2019 | 6386 | 0.040 |
Why?
|
Rats | 3 | 2024 | 24252 | 0.040 |
Why?
|
Cystic Fibrosis | 1 | 2006 | 1178 | 0.040 |
Why?
|
Equipment Failure | 1 | 2000 | 578 | 0.040 |
Why?
|
Fibrin | 1 | 2000 | 506 | 0.040 |
Why?
|
Catheters, Indwelling | 1 | 2000 | 426 | 0.040 |
Why?
|
Factor VIII | 1 | 2000 | 347 | 0.040 |
Why?
|
Fatty Liver, Alcoholic | 1 | 2017 | 40 | 0.040 |
Why?
|
Lactic Acid | 1 | 2022 | 1132 | 0.040 |
Why?
|
Aged | 11 | 2016 | 163288 | 0.040 |
Why?
|
Sensitivity and Specificity | 4 | 2016 | 14723 | 0.040 |
Why?
|
Aorta | 1 | 2004 | 2062 | 0.040 |
Why?
|
Gene Expression Regulation | 3 | 2011 | 12073 | 0.030 |
Why?
|
Immunomodulation | 1 | 2020 | 541 | 0.030 |
Why?
|
Diagnostic Errors | 1 | 2003 | 1257 | 0.030 |
Why?
|
Homosexuality, Male | 1 | 2004 | 1240 | 0.030 |
Why?
|
T-Lymphocyte Subsets | 1 | 2004 | 1837 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 3 | 2014 | 20130 | 0.030 |
Why?
|
Embolization, Therapeutic | 1 | 2006 | 1392 | 0.030 |
Why?
|
Colitis | 1 | 2004 | 1170 | 0.030 |
Why?
|
Liver Diseases | 1 | 2004 | 1253 | 0.030 |
Why?
|
Killer Cells, Natural | 1 | 2004 | 2133 | 0.030 |
Why?
|
Liver Diseases, Alcoholic | 1 | 2017 | 161 | 0.030 |
Why?
|
Mice | 9 | 2018 | 81201 | 0.030 |
Why?
|
Infusions, Subcutaneous | 1 | 2014 | 42 | 0.030 |
Why?
|
Fibrosis | 1 | 2021 | 2029 | 0.030 |
Why?
|
Cell Nucleus | 1 | 2003 | 2969 | 0.030 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2015 | 224 | 0.030 |
Why?
|
Combined Modality Therapy | 2 | 1998 | 8642 | 0.030 |
Why?
|
Reproducibility of Results | 3 | 2018 | 19905 | 0.030 |
Why?
|
Decision Trees | 1 | 2016 | 506 | 0.030 |
Why?
|
Immunity, Cellular | 1 | 2020 | 1607 | 0.030 |
Why?
|
Hepatitis C | 1 | 2004 | 1591 | 0.030 |
Why?
|
Hematoxylin | 1 | 1993 | 64 | 0.030 |
Why?
|
DNA, Viral | 2 | 2016 | 2227 | 0.030 |
Why?
|
Eosine Yellowish-(YS) | 1 | 1993 | 72 | 0.030 |
Why?
|
Antibiotics, Antineoplastic | 1 | 1997 | 692 | 0.030 |
Why?
|
Lipid Peroxidation | 1 | 2014 | 270 | 0.030 |
Why?
|
Emulsions | 1 | 1993 | 156 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 3 | 1999 | 9240 | 0.030 |
Why?
|
Iopamidol | 1 | 1993 | 191 | 0.030 |
Why?
|
Ligands | 1 | 2020 | 3282 | 0.030 |
Why?
|
Research Report | 1 | 2016 | 355 | 0.030 |
Why?
|
Diabetic Nephropathies | 1 | 2000 | 984 | 0.030 |
Why?
|
Radiation Dosage | 1 | 2021 | 1928 | 0.030 |
Why?
|
Radiography, Interventional | 2 | 2006 | 1095 | 0.030 |
Why?
|
Matrix Metalloproteinase 1 | 1 | 2012 | 141 | 0.030 |
Why?
|
Hepatitis | 1 | 2014 | 227 | 0.030 |
Why?
|
Bronchoscopes | 1 | 2012 | 64 | 0.030 |
Why?
|
Viral Core Proteins | 1 | 2012 | 162 | 0.030 |
Why?
|
Observer Variation | 1 | 2018 | 2593 | 0.030 |
Why?
|
Drug Discovery | 1 | 2020 | 1058 | 0.030 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 1999 | 1381 | 0.030 |
Why?
|
Carcinoma, Adenoid Cystic | 1 | 1994 | 252 | 0.030 |
Why?
|
Prospective Studies | 4 | 2021 | 53290 | 0.030 |
Why?
|
Epithelial Cells | 1 | 2003 | 3690 | 0.020 |
Why?
|
Area Under Curve | 1 | 2015 | 1655 | 0.020 |
Why?
|
Disease Models, Animal | 4 | 2014 | 18034 | 0.020 |
Why?
|
Age Factors | 4 | 2009 | 18373 | 0.020 |
Why?
|
Up-Regulation | 1 | 2020 | 4222 | 0.020 |
Why?
|
Mice, Inbred ICR | 1 | 2011 | 352 | 0.020 |
Why?
|
Retrospective Studies | 6 | 2021 | 77460 | 0.020 |
Why?
|
Colorectal Neoplasms | 2 | 2003 | 6773 | 0.020 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2014 | 644 | 0.020 |
Why?
|
Renal Dialysis | 1 | 2000 | 1783 | 0.020 |
Why?
|
Interferon-gamma | 2 | 2012 | 3207 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2021 | 2727 | 0.020 |
Why?
|
Breast Neoplasms | 2 | 1998 | 20824 | 0.020 |
Why?
|
Muscle, Smooth | 1 | 1994 | 934 | 0.020 |
Why?
|
Macrophages | 1 | 2004 | 5660 | 0.020 |
Why?
|
alpha-Macroglobulins | 1 | 2009 | 64 | 0.020 |
Why?
|
Adenoma | 2 | 2003 | 2174 | 0.020 |
Why?
|
gamma-Glutamyltransferase | 1 | 2009 | 134 | 0.020 |
Why?
|
Incidence | 2 | 2000 | 20952 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2014 | 2184 | 0.020 |
Why?
|
Microscopy, Video | 2 | 2000 | 245 | 0.020 |
Why?
|
Time Factors | 3 | 2019 | 40075 | 0.020 |
Why?
|
Esophageal and Gastric Varices | 1 | 2010 | 207 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 3873 | 0.020 |
Why?
|
Injections, Intravenous | 2 | 2003 | 1420 | 0.020 |
Why?
|
Colonic Neoplasms | 1 | 2000 | 2542 | 0.020 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2016 | 1581 | 0.020 |
Why?
|
Serum | 1 | 2009 | 214 | 0.020 |
Why?
|
Receptors, Leptin | 1 | 2009 | 361 | 0.020 |
Why?
|
Administration, Oral | 2 | 2006 | 3914 | 0.020 |
Why?
|
Iodide Peroxidase | 1 | 2009 | 293 | 0.020 |
Why?
|
Bilirubin | 1 | 2009 | 425 | 0.020 |
Why?
|
Hepatitis B e Antigens | 1 | 2007 | 133 | 0.020 |
Why?
|
Mice, Inbred CFTR | 1 | 2006 | 19 | 0.020 |
Why?
|
Interleukin-10 | 1 | 2012 | 1200 | 0.020 |
Why?
|
Viral Load | 1 | 2016 | 3300 | 0.020 |
Why?
|
Mice, Congenic | 1 | 2006 | 99 | 0.020 |
Why?
|
Adipokines | 1 | 2009 | 320 | 0.020 |
Why?
|
Deglutition Disorders | 1 | 2012 | 606 | 0.020 |
Why?
|
Ultrasonography | 2 | 2015 | 5984 | 0.020 |
Why?
|
RNA Splicing | 1 | 2011 | 908 | 0.020 |
Why?
|
Lectins | 1 | 2009 | 513 | 0.020 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2001 | 4034 | 0.020 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1994 | 2232 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2014 | 1888 | 0.020 |
Why?
|
Arachidonic Acid | 1 | 2006 | 434 | 0.020 |
Why?
|
Salivary Glands | 1 | 2006 | 229 | 0.020 |
Why?
|
Heat-Shock Proteins | 1 | 2009 | 822 | 0.020 |
Why?
|
Neoplasm Transplantation | 2 | 2000 | 2086 | 0.020 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily B | 1 | 2004 | 82 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2014 | 6621 | 0.020 |
Why?
|
Acute Disease | 2 | 2006 | 7147 | 0.020 |
Why?
|
Lung Diseases | 1 | 1994 | 1887 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2020 | 19233 | 0.020 |
Why?
|
Cholesterol, Dietary | 1 | 2004 | 231 | 0.010 |
Why?
|
Ileum | 1 | 2006 | 565 | 0.010 |
Why?
|
Risk Assessment | 2 | 2009 | 23336 | 0.010 |
Why?
|
Anus Diseases | 1 | 2004 | 59 | 0.010 |
Why?
|
Rupture, Spontaneous | 1 | 2004 | 354 | 0.010 |
Why?
|
Antigens, CD1d | 1 | 2004 | 220 | 0.010 |
Why?
|
Dextran Sulfate | 1 | 2004 | 236 | 0.010 |
Why?
|
Antiviral Agents | 1 | 2016 | 2987 | 0.010 |
Why?
|
Hemorrhage | 1 | 1994 | 3461 | 0.010 |
Why?
|
Radiography | 2 | 2009 | 7023 | 0.010 |
Why?
|
Mice, Nude | 2 | 2000 | 3689 | 0.010 |
Why?
|
Interleukin-13 | 1 | 2004 | 389 | 0.010 |
Why?
|
Skin Neoplasms | 1 | 2001 | 5692 | 0.010 |
Why?
|
Models, Immunological | 1 | 2004 | 527 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 2 | 2024 | 35425 | 0.010 |
Why?
|
United States | 3 | 2016 | 69872 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2017 | 13991 | 0.010 |
Why?
|
Polymerase Chain Reaction | 2 | 2001 | 6171 | 0.010 |
Why?
|
Lectins, C-Type | 1 | 2004 | 589 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2015 | 12356 | 0.010 |
Why?
|
Glycoproteins | 1 | 2009 | 2266 | 0.010 |
Why?
|
Tumor Cells, Cultured | 2 | 2000 | 6313 | 0.010 |
Why?
|
Alkaline Phosphatase | 1 | 2004 | 867 | 0.010 |
Why?
|
Survival Analysis | 1 | 1993 | 10252 | 0.010 |
Why?
|
Prognosis | 2 | 2011 | 29060 | 0.010 |
Why?
|
Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor | 1 | 1999 | 43 | 0.010 |
Why?
|
Subtraction Technique | 1 | 2003 | 525 | 0.010 |
Why?
|
Genomics | 1 | 2016 | 5717 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2016 | 8432 | 0.010 |
Why?
|
Antigens, Surface | 1 | 2004 | 1663 | 0.010 |
Why?
|
Pancreas | 1 | 2006 | 1687 | 0.010 |
Why?
|
Polymorphism, Single-Stranded Conformational | 1 | 1999 | 335 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 1993 | 12244 | 0.010 |
Why?
|
Gene Expression | 1 | 2012 | 7798 | 0.010 |
Why?
|
Homozygote | 1 | 2004 | 1787 | 0.010 |
Why?
|
Exudates and Transudates | 1 | 1999 | 172 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2006 | 39052 | 0.010 |
Why?
|
Th1 Cells | 1 | 2004 | 1057 | 0.010 |
Why?
|
Survival Rate | 1 | 1993 | 12788 | 0.010 |
Why?
|
Th2 Cells | 1 | 2004 | 1061 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2014 | 13035 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2004 | 1375 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2011 | 9735 | 0.010 |
Why?
|
Antigen Presentation | 1 | 2004 | 1284 | 0.010 |
Why?
|
Radiographic Image Enhancement | 1 | 2003 | 885 | 0.010 |
Why?
|
Rabbits | 1 | 2004 | 4894 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2006 | 4777 | 0.010 |
Why?
|
Injections, Intra-Arterial | 1 | 1997 | 193 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 2001 | 1950 | 0.010 |
Why?
|
Hepatocytes | 1 | 2004 | 1211 | 0.010 |
Why?
|
Boston | 1 | 2010 | 9312 | 0.010 |
Why?
|
Tail | 1 | 1997 | 97 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2007 | 2716 | 0.010 |
Why?
|
Heterozygote | 1 | 2004 | 2804 | 0.010 |
Why?
|
Erythrocytes | 1 | 2006 | 2455 | 0.010 |
Why?
|
Signal Transduction | 1 | 2020 | 23404 | 0.010 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 1999 | 659 | 0.010 |
Why?
|
Mutation | 2 | 2016 | 29786 | 0.010 |
Why?
|
Hepatic Artery | 1 | 1997 | 245 | 0.010 |
Why?
|
Transfection | 1 | 2004 | 5895 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2011 | 4925 | 0.010 |
Why?
|
Colon | 1 | 2004 | 1772 | 0.010 |
Why?
|
Insulin Resistance | 1 | 2009 | 3864 | 0.010 |
Why?
|
Cholesterol | 1 | 2004 | 2919 | 0.010 |
Why?
|
HIV Infections | 1 | 2001 | 16715 | 0.010 |
Why?
|
Sex Factors | 1 | 2009 | 10400 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2009 | 11726 | 0.010 |
Why?
|
Portal Vein | 1 | 1997 | 437 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2011 | 16690 | 0.010 |
Why?
|
Gene Rearrangement | 1 | 1999 | 1179 | 0.010 |
Why?
|
Liposomes | 1 | 1997 | 759 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 1998 | 13104 | 0.010 |
Why?
|
Lung | 2 | 2006 | 9857 | 0.010 |
Why?
|
Drug Carriers | 1 | 1997 | 693 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2012 | 25039 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2000 | 6366 | 0.010 |
Why?
|
Body Mass Index | 1 | 2009 | 12721 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 1997 | 2700 | 0.010 |
Why?
|
Cell Line | 1 | 2004 | 16000 | 0.010 |
Why?
|
Contrast Media | 1 | 2003 | 5300 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2006 | 63107 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2006 | 57776 | 0.010 |
Why?
|
Transcription Factors | 1 | 2009 | 12207 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 1997 | 8300 | 0.000 |
Why?
|
Cohort Studies | 1 | 2007 | 40559 | 0.000 |
Why?
|
Risk Factors | 1 | 2009 | 72296 | 0.000 |
Why?
|